CompletedNCT00818298

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Medication studyAges 18–60CanadaSchizophrenia

The study in practice

Understand this study

Listed age limits: 18 years to 60 years.

Study clarity

Study start dateJanuary 2009

Recruitment status: Completed
Enrollment listed in the registry: 12
Sponsor: Centre for Addiction and Mental Health
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: Canada
Age range: From 18 Years to 60 Years
Official registry ID: NCT00818298
Official title: Show the full official title
24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Completed

Toronto

FAQ

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including ziprazidone.

Who was this study for?

Listed age limits: 18 years to 60 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.